By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    health benefits of taking a vacation to reduce stress
    Relaxing European Destinations to Reduce Stress Risks to Health
    October 11, 2021
    pain management tips
    Managing Pain Differently: Alternative Pain Management Techniques
    January 12, 2022
    5 Ways to Promote Wellness in Your Home
    April 12, 2022
    Latest News
    How to Recognize the Signs of Hormonal Imbalance in Men
    May 27, 2023
    4 Signs It’s Time to See a Therapist
    May 24, 2023
    11 Ways To Modernize Your Private Practice
    May 17, 2023
    Important Steps to Take for Scaling A Biopharma Product
    May 2, 2023
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    patient-centered care
    Humanism in Medicine Essay on Fear, Trust and the Love That Is Patient-Centered Care
    November 26, 2013
    Pay or Play
    Play or Pay: The Triple Aim for 2015 and Beyond
    June 16, 2014
    pharmaphorum
    Pharma Is from Mars, Patients Are from Venus
    April 2, 2015
    Latest News
    MRI Sedation Options: What You Should Know Before Screening
    May 17, 2023
    What is the Process of Creating Medicine from Nature?
    May 2, 2023
    Choosing the Right Treatment Option for Varicose Veins
    May 2, 2023
    What Are Wrong-Site Surgeries and How Do They Occur?
    April 27, 2023
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Promising Malaria Vaccine
Share
Sign In
Notification Show More
Aa
Health Works CollectiveHealth Works Collective
Aa
Search
Have an existing account? Sign In
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Global Healthcare > Promising Malaria Vaccine
Global Healthcare

Promising Malaria Vaccine

Amanda Glassman
Last updated: 2011/10/25 at 7:13 AM
Amanda Glassman
Share
5 Min Read
SHARE

 

 

News this month that an experimental vaccine cuts in half the risk of malaria in children in Africa is a welcome success story 20+ years in the making. It’s also a rare bright spot in the clinical trials labyrinth that stands between promising new medicines, vaccines, and diagnostic techniques and the one billion people in the developing world who suffer from one or more neglected diseases. Ninety other drug and vaccine candidates for neglected diseases are waiting in the pipeline for late stage clinical development. Under current arrangements, they will face lengthy, inefficient reviews in countries where the regulatory capacity ranges from weak to non-existent.

Related Content

More Read

everest healthcare

The Everest Foundation’s Mission to Support Inclusive Healthcare

Using EHR systems in healthcare for Cost-Effective Services
Benefits of Emerging Technology in Healthcare in 2023
Simplifying the Genetic Testing Process: How At-Home Kits are Changing the Game
Why a Health Retreat Can Be the Best Medicine
  • Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases (Event)
  • Clinical Trials and Regulatory Pathways for Neglected Diseases (Working Group)

Funding from major donors such as the Bill and Melinda Gates Foundation, Wellcome Trust , Médecins Sans Frontières (MSF) and the World Health Organization has led to an upsurge in new products—including vaccines for diseases like TB, cholera and dengue fever. These funders now face huge costs in bringing the new compounds they helped to develop to market.

Meanwhile, neglected diseases take a heavy toll. Malaria and TB alone kill an estimated 2.1 million people annually, nearly all in low-and middle income countries. Lesser known diseases, like human African trypanosomiasis, chagas disease, leishmaniasis, dengue fever and leprosy kill another half a million people.

These diseases are most widespread precisely where the capacity to test new therapies is most lacking. To assure scientific validity, new compounds must often be tested in several countries, each with their own regulatory authorities and ethical review boards, which are often weak and lacking in transparency.

What does it take to get a new treatment through the pipeline and into the hands of a patient who needs it? A 2008 article in the Lancet cited two examples where trials for TB treatments had been delayed by a year or more due to regulatory hurdles. One trial needed approval from 18 authorities in six countries and was stalled for two years before patient recruitment could begin. Yet the primary drug in this study, Rifapetine, had already been approved by the U.S. Food and Drug Administration (FDA) in 1998.

Unfortunately, this story isn’t unique. In many countries where neglected diseases are endemic, approval of clinical trials can take as long as 6-24 months. For products that require multiple trials in different populations, subsequent application approvals may take an additional 6-24 months or longer. Approval for an amendment to a trial protocol can take up to four months in a low-income setting. In contrast, regulatory approval for trials in the United States and the European Union can generally be obtained within 30-60 days, and trial protocol amendments take only a few weeks.

Long delays in protocol approvals raise costs, eroding the limited funding available to find cures for neglected diseases and bring them to market. According to a recent report by the G-FINDER project, in 2009 the total global spending on TB drug development was just $180 million, with nearly eight out of ten dollars coming from public funders and philanthropic organizations. These scarce funds could go much farther with improved regulatory pathways and clinical trial protocols.

We believe this is a problem that can be fixed. On Monday, October 31st, CGD will release a new report, Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases. Prepared by a CGD working group led by Tom Bollyky and comprising 22 experts from diverse backgrounds including medicine, law, ethics, government, industry, public-private partnerships, and international development, the report offers technically sound and politically feasible recommendations for overcoming the clinical trials labyrinth. We are delighted that FDA Commissioner Margaret Hamburg will kick off the event with a keynote speech.

We hope that you can join us!

This is a joint post with Tom Bollyky

TAGGED: malaria vaccine

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Amanda Glassman October 25, 2011
Share this Article
Facebook Twitter Copy Link Print
Share
By Amanda Glassman
As a healthcare blogger and author, I have been writing about the latest developments in the medical field for over 10 years. My work has been featured on various online publications, including Healthline and WebMD. I am passionate about educating people on how to stay healthy through proper nutrition and exercise practices. In addition to my blog posts, I have also authored several books that focus on health topics such as dieting tips, disease prevention strategies, and mental health awareness initiatives. My goal is to provide readers with reliable information so they can make informed decisions regarding their well-being.
Previous Article FDA Cautions Against Pharma-Jet Needle-Free Flu Shots
Next Article Social Media, Diet and Cancer

Stay Connected

1.5k Followers Like
4.5k Followers Follow
2.8k Followers Pin
136k Subscribers Subscribe

Latest News

How to Recognize the Signs of Hormonal Imbalance in Men
How to Recognize the Signs of Hormonal Imbalance in Men
Health May 27, 2023
nursing trends and predictions
Biggest Nursing Trends and Predictions for 2023
Nursing May 25, 2023
medical answering service
How Medical Answering Services Can Improve Patient Care
Technology May 25, 2023
healthy parenting
4 Ways Parents Can Raise a Healthy and Happy Child
Parenting May 25, 2023

You Might also Like

MRI sedation options
Global Healthcare

MRI Sedation Options: What You Should Know Before Screening

May 17, 2023
medicines from nature
Global Healthcare

What is the Process of Creating Medicine from Nature?

May 2, 2023
US healthcare system
Global Healthcare

3 Ways to Improve the U.S. Healthcare System By 2030

March 14, 2023
Clinical Studies
Global Healthcare

6 Steps To Ensure Speed And Efficiency Of Clinical Studies

March 14, 2023
//

We influence million of users and is the most authentic source of information on healthcare business and technology news.

Quick Links

  • About
  • Contact
  • Privacy
Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Follow US

© 2008-2023 HealthWorks Collective. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?